Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Nordson beats Q3 2025 forecasts with strong revenue growth and completes Atrion integration
Nordson reported Q3 2025 EPS of $2.73 (vs. forecast $2.63) and revenue of $742 million, both above expectations, prompting a notable after-hours share rise. The company posted 12% year‑over‑year revenue growth, completed the Atrion acquisition integration ahead of schedule and announced the planned sale of its contract manufacturing business in the medical‑technology area for Q4. Management expects full‑year EPS to come in slightly above estimates and anticipates improvements in the IPS segment with a return to normal growth in the medical‑technology segment by 2026. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | - |
| Net profit | 187.16K | 183.83% |
| EBITDA | 0 | 100.00% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €182.39K |
Number of shares | 334.1M |
52-week high/low | €0.000546 - €0.000364 |
| Dividends | No |
Beta | 6.61 |
P/E ratio | 0.47 |
PEG ratio | 0.00 |
P/B ratio | 0.49 |
P/S ratio | 0.00 |
Company profile
Etrion Corporation does not have significant business operations. Previously, the company operated as an independent renewable energy developer in Japan. The company was formerly known as PetroFalcon Corporation and changed its name to Etrion Corporation in September 2009. Etrion Corporation was incorporated in 1993 and is based in Geneva, Switzerland.
| Name | Etrion Corp |
| CEO | Marco Antonio Northland |
| Headquarters | Vancouver,
bc Switzerland |
| Website | |
| IPO | 02/07/2011 |
| Employees | 20 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | ETRXF |